Pay in 4 interest-free payments of $5.12 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
BPC-157 is a gastric-derived peptide that supports vascular and soft-tissue systems
The hepatic metabolism pathway for BPC-157 means the peptide passes through the liver where many medications are also processed
Safety Profile: What Clinical Trials Actually Documented Across six clinical trials involving approximately 900 participants, AOD-9604 produced no treatment-related serious adverse events, no immunogenic response, no IGF-1 elevation, and no adverse cardiovascular or metabolic signals
Determining your personal response requires trial, ideally with some attempt at blinding to reduce bias
This article stays tightly focused on the weight-loss question: what BPC-157 is, what evidence exists, what could plausibly influence body composition indirectly, why some people report the opposite outcome, and the safety/regulatory issues you should understand before taking claims at face value
